The US health department, led by Robert F. Kennedy Jr., is evaluating modifications to the categorization and description of vaccine recommendations. This initiative could lead to current "routine" or "universal" vaccinations being reclassified with designations such as "recommended with qualification" or "recommended based on shared clinical decision-making."
Kennedy has not yet implemented new rules but has outlined possibilities in a Request for Information (RFI) published in the Federal Register. The RFI, a 10-page document, seeks public input on existing categories and ideas for new ones, with a comment deadline of September 20.
Currently, the Centers for Disease Control and Prevention (CDC), advised by the Advisory Committee on Immunization Practices (ACIP), uses three categories for vaccination recommendations. These include "routine" (universal recommendation), "risk-based" (for specific high-risk groups), and "shared clinical decision-making" (SCDM), which allows for flexible recommendations based on patient characteristics and provider judgment.
Before Kennedy's oversight, the CDC and ACIP utilized an evidence-based framework for determining recommendation types. The RFI does not present clear, evidence-based justifications for questioning or changing the current categories. Kennedy's efforts are prefaced by a recent executive order signed by Trump, which aimed to overhaul federal vaccine recommendations.
✨ This summary was generated by AI from the outlets' reporting listed below. It is not independently verified and may contain errors — check the original sources. How BrevFeed works →
One email each morning: the day's tech stories, clustered across outlets and summarized. No account needed.
One email a day. Unsubscribe in one click, any time.
Spend a few minutes, get the whole day. Every topic's top stories in one hands-free rundown — listen, watch, or read the transcript.
▶ Play today's briefNew every morning, and the back catalogue is archived by date.
The US health department, under Robert F. Kennedy Jr., is exploring changes to how vaccine recommendations are categorized, potentially introducing less definitive designations. This move could alter the perception and communication of vaccine guidance from the Centers for Disease Control and Prevention (CDC).